Drugs / Bevasizumab
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01178697 Comparator | Jan → Sep 2010 | central retinal vein occlusion | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bevasizumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01178697 ↗ |
| Route | Intravitreal | “Intravitreal, 1.25 mg, 3 times, one month apart.” NCT01178697 ↗ |